Fate Therapeutics
FATE
#8977
Rank
C$0.15 B
Marketcap
$1.34
Share price
-1.46%
Change (1 day)
-86.99%
Change (1 year)

P/E ratio for Fate Therapeutics (FATE)

P/E ratio as of March 2025 (TTM): -0.4309

According to Fate Therapeutics 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.430876. At the end of 2022 the company had a P/E ratio of -3.47.

P/E ratio history for Fate Therapeutics from 2013 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-3.47-86.78%
2021-26.2-39.98%
2020-43.7219.44%
2019-13.728%
2018-10.778.49%
2017-5.99152.97%
2016-2.37-14.98%
2015-2.79-30.23%
2014-3.99-18.2%
2013-4.88

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-12.7 2,847.60%๐Ÿ‡บ๐Ÿ‡ธ USA
40.4-9,486.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-6.24 1,349.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-10.5 2,342.88%๐Ÿ‡บ๐Ÿ‡ธ USA
56.1-13,121.63%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.